EPM Pharma Invest SRL
EPM Pharma Invest reported total assets of 110,215 € at the end of the 2025 financial year (annual accounts filed with the NBB on 17 Jun 2026).
The score of EPM Pharma Invest shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity -27 % Total assets -27 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
EPM Pharma Invest's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 17 Jun 2026
- Year ended 31 Dec 2024filed on 12 Jun 2025
- Year ended 31 Dec 2023filed on 10 Jun 2024
- Year ended 31 Dec 2022filed on 14 Jun 2023
- Year ended 31 Dec 2021filed on 13 Jun 2022
EPM Pharma Invest's financial analysis
- Solvency99.5%sector median: 53.1%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of EPM Pharma Invest
EPM Pharma Invest's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0538.590.817
- VAT number
- BE0538590817
- Peppol
- Not found on Peppol as of 10 Nov 2026 · Check
- Legal form
- SRL
- Incorporated
- 09 Sep 2013
- Registered office
- 9830 Sint-Martens-Latem
- Latest accounts
- 2025 · filed on 17 Jun 2026
- Activity
- Activities of head offices (NACE 7010001)
EPM Pharma Invest (SRL) has been based in Sint-Martens-Latem since 2013, active in: activities of head offices. For 2025, it reports a net loss of 33,175 € and equity of 109,705 €; its revenue is not published. Its solvency stands at 99.5%, above the median of its sector (53.1%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to EPM Pharma Invest
Companies in the same business, of comparable size and area, outside its group.
- LI Soins Nursing and midwifery activities La Louvière · balance sheet 110,299 €
- 2B2² Antwerp · balance sheet 110,130 €
- Patrimoniale LouVe-LiNah Ath · balance sheet 110,064 €
- Flex Quarters Activities of holding companies Antwerp · balance sheet 109,947 €
- 1979 Education Ventures Saint-Gilles · balance sheet 110,535 €
- Immo Nelis Activities of holding companies Oudsbergen · balance sheet 110,578 €
- Sainte Catherine Activities of holding companies Ostend · balance sheet 110,612 €
Frequently asked questions about EPM Pharma Invest
What is the revenue of EPM Pharma Invest?
EPM Pharma Invest files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of EPM Pharma Invest?
In Belgium, the VAT number is the company number prefixed with BE: BE0538590817 for EPM Pharma Invest, if the company is VAT-registered. Its company number (CBE) is 0538.590.817.
Where is the registered office of EPM Pharma Invest?
According to the CBE register, the registered office of EPM Pharma Invest is in 9830 Sint-Martens-Latem.
What is the equity of EPM Pharma Invest?
At the close of the 2025 financial year, the equity of EPM Pharma Invest amounts to 109,705 €, a solvency of 99.5% of total assets.
Who manages EPM Pharma Invest?
The register lists 3 active mandates at EPM Pharma Invest. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of EPM Pharma Invest
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →